← Leaderboards
Jordi Ochando
Icahn School Of Medicine At Mount Sinai
$5,634,948
Attributed
$6,312,259
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,312,259 · 8
By mechanism
R01$2,267,859 · 1
P30$1,663,908 · 4
P01$1,399,553 · 1
UH3$700,716 · 1
UH2$280,223 · 1
Top collaborators
- Ernesto Guccione3 shared
- Samir Parekh3 shared
- Ivan Marazzi1 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Willem Mulder$11,953,843
- Abraham Teunissen$2,813,520
- Mandy Maria Theresia Van Leent$2,578,599
- Ernesto Guccione$11,143,318
- Samir Parekh$6,034,549
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsResearch PersonnelTrainingLaboratoriesFlow CytometryInnovationSamplingProgramsCancer PatientImmuneEquipmentDoctor Of PhilosophyImmunitySiteResource SharingConsultationsMalignant NeoplasmsMemberFlow Cytometry Shared ResourceCancer Center Support GrantBasic ScienceMissionCost EffectivenessServices
Grant awards (22)
Implementation of a qPCR-based assay for the quantification of SARS-CoV-2-specific T cells in immunocompromised patients$350,358
UH3 · FY2025 · CA
Mechanistic and Bioinformatics Core$347,979
P01 · FY2025 · AI · contact PI
Flow Cytometry$144,816
P30 · FY2025 · CA · contact PI
Mechanistic and Bioinformatics Core$568,871
P01 · FY2024 · AI · contact PI
Implementation of a qPCR-based assay for the quantification of SARS-CoV-2-specific T cells in immunocompromised patients$350,358
UH3 · FY2024 · CA
Flow Cytometry$138,227
P30 · FY2024 · CA · contact PI
Mechanistic and Bioinformatics Core$482,703
P01 · FY2023 · AI · contact PI
Implementation of a qPCR-based assay for the quantification of SARS-CoV-2-specific T cells in immunocompromised patients$280,223
UH2 · FY2023 · CA
Flow Cytometry$138,227
P30 · FY2023 · CA · contact PI
Myeloid Specific Targeted Nanoimunotherapy for Organ Transplant Acceptance$423,750
R01 · FY2022 · AI · contact PI
Flow Cytometry$138,227
P30 · FY2022 · CA · contact PI
Myeloid Specific Targeted Nanoimunotherapy for Organ Transplant Acceptance$423,750
R01 · FY2021 · AI · contact PI
Flow Cytometry$138,227
P30 · FY2021 · CA · contact PI
Myeloid Specific Targeted Nanoimunotherapy for Organ Transplant Acceptance$572,859
R01 · FY2020 · AI · contact PI
Flow Cytometry$138,227
P30 · FY2020 · CA · contact PI
Myeloid Specific Targeted Nanoimunotherapy for Organ Transplant Acceptance$423,750
R01 · FY2019 · AI · contact PI
Flow Cytometry$170,390
P30 · FY2019 · CA · contact PI
Myeloid Specific Targeted Nanoimunotherapy for Organ Transplant Acceptance$423,750
R01 · FY2018 · AI · contact PI
Flow Cytometry$188,340
P30 · FY2018 · CA · contact PI
Flow Cytometry$188,340
P30 · FY2017 · CA · contact PI
Flow Cytometry$188,339
P30 · FY2016 · CA · contact PI
Flow Cytometry$92,548
P30 · FY2015 · CA · contact PI